Copyright
©The Author(s) 2019.
World J Gastroenterol. Aug 7, 2019; 25(29): 4007-4018
Published online Aug 7, 2019. doi: 10.3748/wjg.v25.i29.4007
Published online Aug 7, 2019. doi: 10.3748/wjg.v25.i29.4007
Table 4 Preventive treatments for dermatological toxicities (Primary analysis set, n = 229)
| n = 229 | |
| At least one preventive treatment, n (%) | 151/229 (65.9) |
| Emollients | 114/151 (75.5) |
| Oral antibiotics | 127/151 (84.1) |
| Emollients and oral antibiotics | 95/151 (62.9) |
| Sunscreen | 9/150 (6.0) |
| Topical corticosteroids | 14/151 (9.3) |
| Other (including topical antibiotics) | 33/151 (21.9) |
| Topical antibiotics | 30/33 (90.9) |
- Citation: Bouché O, Ben Abdelghani M, Labourey JL, Triby S, Bensadoun RJ, Jouary T, Des Guetz G. Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer. World J Gastroenterol 2019; 25(29): 4007-4018
- URL: https://www.wjgnet.com/1007-9327/full/v25/i29/4007.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i29.4007